Form 8-K - Current report:
SEC Accession No. 0001567892-24-000040
Filing Date
2024-11-05
Accepted
2024-11-05 06:45:14
Documents
15
Period of Report
2024-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnk-20241105.htm   iXBRL 8-K 26150
2 EX-99.1 mnkexhibit991q32024.htm EX-99.1 571694
6 MNK LOGO mallinckrodtlogoa11a.jpg GRAPHIC 18959
  Complete submission text file 0001567892-24-000040.txt   790170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnk-20241105.xsd EX-101.SCH 2164
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnk-20241105_lab.xml EX-101.LAB 22462
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnk-20241105_pre.xml EX-101.PRE 13154
17 EXTRACTED XBRL INSTANCE DOCUMENT mnk-20241105_htm.xml XML 2709
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1227
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 241425557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)